PubMed=8978593; DOI=10.1159/000227661
Wakahara Y., Nawa A., Okamoto T., Hayakawa A., Kikkawa F., Suganama N., Wakahara F., Tomoda Y.
Combination effect of anti-Fas antibody and chemotherapeutic drugs in ovarian cancer cells in vitro.
Oncology 54:48-54(1997)

PubMed=9344045; DOI=10.1023/A:1018495414975
Shibata K., Kikkawa F., Nawa A., Tamakoshi K., Suganuma N., Tomoda Y.
Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue.
Clin. Exp. Metastasis 15:612-619(1997)

PubMed=10403549; DOI=10.1016/S0304-3835(99)00062-2
Hayakawa A., Yokoyama I., Tajiri H., Okamoto T., Nakashima I.
Protein kinase C-dependent anti-apoptotic mechanism that is associated with high sensitivity to anti-Fas antibody in ovarian cancer cell lines.
Cancer Lett. 140:113-119(1999)

PubMed=11865194; DOI=10.1023/A:1014302212321
Hayakawa A., Wu J., Kawamoto Y., Zhou Y.-W., Tanuma S.-i., Nakashima I., Suzuki H.
Activation of caspase-8 is critical for sensitivity to cytotoxic anti-Fas antibody-induced apoptosis in human ovarian cancer cells.
Apoptosis 7:107-113(2002)

PubMed=12767062; DOI=10.1002/ijc.11177
Kikkawa F., Kajiyama H., Ino K., Shibata K., Mizutani S.
Increased adhesion potency of ovarian carcinoma cells to mesothelial cells by overexpression of dipeptidyl peptidase IV.
Int. J. Cancer 105:779-783(2003)